glp 1 injection site irritation GLP-1 Dermatologic Effects: What Clinicians Should Know Rash from a GLP-1 explained

C.MarcheseN

For example, in June 2025, Connecticut Attorney General released a statement warning businesses of allegedly or potentially unfair and deceptive conduct related to compounding of GLP-1 medications

It was discovered in the 1950s as a result of investigations into a self-limited hemolysis that occurred after administration of the antimalarial drug primaquine, most commonly in individuals of African or Mediterranean ethnic origin

Retatrutide clinical trial data Retatrutide data comes primarily from two sources: a Phase 2 trial published in the New England Journal of Medicine and the Phase 3 TRIUMPH program that began reporting results in mid-2025